| scholarly article | Q13442814 |
| P50 | author | Julien Zuber | Q42859640 |
| P2093 | author name string | F Martinez | |
| C Legendre | |||
| D Anglicheau | |||
| M-O Timsit | |||
| E Thervet | |||
| C Elie | |||
| H Kreis | |||
| C Hiesse | |||
| K Laborde | |||
| L Bererhi | |||
| F Eustache | |||
| M Ciroldi | |||
| M-F Mamzer-Bruneel | |||
| R Snanoudj | |||
| P2860 | cites work | TOR signaling in growth and metabolism | Q27860757 |
| Point mutation in kit receptor tyrosine kinase reveals essential roles for kit signaling in spermatogenesis and oogenesis without affecting other kit responses | Q34668023 | ||
| Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation | Q36155827 | ||
| Pregnancy in recipients of solid organs--effects on mother and child | Q36428848 | ||
| Gonadal impact of target of rapamycin inhibitors (sirolimus and everolimus) in male patients: an overview | Q36746801 | ||
| Sirolimus-associated infertility: case report and literature review of possible mechanisms | Q36936424 | ||
| Stem cell factor/c-kit up-regulates cyclin D3 and promotes cell cycle progression via the phosphoinositide 3-kinase/p70 S6 kinase pathway in spermatogonia | Q43503981 | ||
| Rapamycin-induced oligospermia | Q44591465 | ||
| Testosterone concentrations and sirolimus in male renal transplant patients. | Q44695059 | ||
| Sirolimus impairs gonadal function in heart transplant recipients | Q44935460 | ||
| Sirolimus impairs improvement of the gonadal function after renal transplantation | Q45214578 | ||
| Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of cyclosporine, and basiliximab. | Q46468654 | ||
| The pituitary-testicular axis in men with chronic renal failure | Q48286329 | ||
| Gonadal dysfunction in uremic men. A study of the hypothalamo-pituitary-testicular axis before and after renal transplantation | Q48463482 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sirolimus | Q32089 |
| P304 | page(s) | 1471-1479 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Sirolimus may reduce fertility in male renal transplant recipients | |
| P478 | volume | 8 |
| Q38041260 | A drug safety evaluation of everolimus in kidney transplantation |
| Q35147537 | A prospective study in male recipients of kidney transplantation reveals divergent patterns for inhibin B and testosterone secretions |
| Q38068519 | Adverse events associated with mTOR inhibitors |
| Q37929851 | Clinical application of mTORi based immunosuppression for renal transplantation in India |
| Q43808149 | Conversion to sirolimus in pediatric renal transplant patients: a single-center experience |
| Q37992135 | Everolimus: preventing organ rejection in adult kidney transplant recipients |
| Q47731603 | FDA-approved drugs that are spermatotoxic in animals and the utility of animal testing for human risk prediction |
| Q28068325 | FDA-approved medications that impair human spermatogenesis |
| Q46153680 | Gender issues and drug use pattern in kidney transplantation: experience of a medical center in southern Taiwan |
| Q43272678 | Gonadal dysfunction and infertility in kidney transplant patients receiving sirolimus |
| Q46236864 | Immunosuppressants and Male Reproduction |
| Q87866782 | Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era |
| Q26778587 | Immunosuppressive drugs and fertility |
| Q38131036 | Impact of mTOR-I on fertility and pregnancy: state of the art and review of the literature. |
| Q48165645 | Inhibition of mTOR pathway decreases the expression of pre-meiotic and meiotic markers throughout postnatal development and in adult testes in mice. |
| Q37054920 | Long-term impact of immunosuppressants at therapeutic doses on male reproductive system in unilateral nephrectomized rats: a comparative study |
| Q64098157 | Male infertility in renal failure and transplantation |
| Q39104277 | Mammalian target of rapamycin (mTOR): a central regulator of male fertility? |
| Q36271477 | Mammalian target of rapamycin complex 1 (mTORC1) Is required for mouse spermatogonial differentiation in vivo |
| Q36508069 | Management of children after renal transplantation: highlights for general pediatricians |
| Q92937610 | Mechanistic target of rapamycin (mTOR) implicated in plasticity of the reproductive axis during social status transitions |
| Q92333425 | Mechanistic target of rapamycin kinase (Mtor) is required for spermatogonial proliferation and differentiation in mice |
| Q64085474 | Molecular Mechanisms Controlled by mTOR in Male Reproductive System |
| Q91028117 | New insights into the role of mTORC1 in male fertility in zebrafish |
| Q46967156 | Parenthood in pediatric liver transplant patients |
| Q36541052 | Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes |
| Q28484885 | Profiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational study |
| Q35064974 | Promoting autophagic clearance: viable therapeutic targets in Alzheimer's disease |
| Q28286510 | Rapalogs and mTOR inhibitors as anti-aging therapeutics |
| Q54250332 | Rapamycin (Sirolimus) alters mechanistic target of rapamycin pathway regulation and microRNA expression in mouse meiotic spermatocytes. |
| Q34275079 | Rapamycin slows aging in mice |
| Q50084953 | Rictor/mTORC2 regulates blood-testis barrier and spermatogenesis in mice |
| Q38268775 | Safety considerations of mammalian target of rapamycin inhibitors in tuberous sclerosis complex and renal transplantation |
| Q58767032 | Sexual aspects of liver transplant candidates and recipients: evidence available in the literature1 |
| Q37779484 | Sirolimus for calcineurin inhibitors in organ transplantation: contra |
| Q36423641 | Successful fertility restoration after allogeneic hematopoietic stem cell transplantation |
| Q38866277 | Surveillance biopsies after paediatric kidney transplantation: A review |
| Q26823023 | Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitors |
| Q38722243 | The impact of drugs on male fertility: a review. |
| Q37988902 | The impact of sirolimus on sex hormones in male adolescent kidney recipients |
| Q38043510 | The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation |
| Q43175110 | The use of mTOR inhibitors in kidney transplantation: who are the best patients and how should these inhibitors be used? |
| Q89288858 | Tuberous sclerosis complex |
| Q54446794 | [mTORC1 and sirolimus: a link with fertility]. |
| Q92619521 | mTOR inhibitor sirolimus negatively impacts in vitro fertilization outcomes |
| Q38962103 | mTOR inhibitors in pancreas transplant: adverse effects and drug-drug interactions |
Search more.